Collins Helen Louise 4
4 · Kura Oncology, Inc. · Filed Jun 7, 2024
Insider Transaction Report
Form 4
Collins Helen Louise
Director
Transactions
- Award
Option to purchase common stock
2024-06-05+26,000→ 26,000 totalExercise: $21.79Exp: 2034-06-04→ Common Stock (26,000 underlying)
Footnotes (1)
- [F1]This option vests in full on the one year anniversary of the date of grant.